China Money Network
Login
Join

Immunophage Biotech Gets $14M In Pre-A Round

  • May 5, 2020 — 15:14 CST

This Data Is Locked!

This area is available only to Subscribers.

Immunophage Biotech, a Nanjing-based pharmaceutic company, has recently completed a Pre-A round of financing of nearly RMB100 million (US$14.2 million), led by Jinfang Hongrui Investment... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: